Physician profile
Barbara L Phillips
NPI 1073522991
$1,939.68
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,749 · 2020: $14.77 · 2023: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $245.87 | 2019 | |
| Allergan, INC. | $175.12 | 2019-2020 | |
| Pfizer INC. | $169.82 | 2019 | |
| Abbvie INC. | $160.45 | 2023 | |
| Astellas Pharma US INC | $136.70 | 2019 | |
| Glaxosmithkline, LLC. | $135.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $118.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.79 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $69.49 | 2019 | |
| Lilly USA, LLC | $69.29 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $67.39 | 2019 | |
| Amgen INC. | $58.36 | 2019 | |
| Sanofi-Aventis U.S. LLC | $56.46 | 2019 | |
| Scilex Pharmaceuticals INC. | $51.46 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $42.29 | 2019 | |
| Shire North American Group INC | $39.24 | 2019 | |
| Merck Sharp & Dohme LLC | $28.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.77 | 2019 | |
| Sanofi Pasteur INC. | $20.99 | 2019 | |
| Genentech USA, INC. | $20.83 | 2019 | |
| Eisai INC. | $20.27 | 2019 | |
| Exact Sciences Corporation | $15.19 | 2023 | Cologuard Collection Kit |
| Nalpropion Pharmaceuticals LLC | $13.22 | 2019 | |
| Seqirus USA INC | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.